A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
暂无分享,去创建一个
P. Chomez | T. Boon | E. De Plaen | P. van der Bruggen | C. Traversari | C. Lurquin | B. J. Van den Eynde | A. Knuth | E. de Plaen | Patrick Chomez | Thierry Boon | Catia Traversari | P vanderBruggen | Christophe Lurquin | E DePlaen | Van den Eynde Bj | Alexander Knuth | P. vanderBruggen | E. DePlaen | Van den Eynde Bj
[1] T. Boon,et al. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice , 1991, The Journal of experimental medicine.
[2] P. Chomez,et al. Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide , 1990, The Journal of experimental medicine.
[3] C. Slingluff,et al. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas. , 1990, Cancer research.
[4] R. Fauchet,et al. Presence on a human melanoma of multiple antigens recognized by autologous CTL , 1989, International journal of cancer.
[5] T. Boon,et al. Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cells , 1989, Cell.
[6] M. Hansen,et al. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.
[7] C. Slingluff,et al. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. , 1989, Journal of immunology.
[8] M. Frohman,et al. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[9] B. Vogelstein,et al. Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene. , 1988, Cancer research.
[10] P. Chomez,et al. Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Lipman,et al. Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Devos,et al. Production of stable cytolytic T‐cell clones directed against autologous human melanoma , 1987, International journal of cancer.
[13] S. Ferrone,et al. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity. , 1986, Journal of immunology.
[14] Y. Kan,et al. Versatile cosmid vectors for the isolation, expression, and rescue of gene sequences: studies with the human alpha-globin gene cluster. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[15] T. Boon,et al. Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis , 1983, The Journal of experimental medicine.
[16] C. Uyttenhove,et al. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression , 1983, The Journal of experimental medicine.
[17] F. Grosveld,et al. Isolation of transforming DNA by cosmid rescue. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Macdonald,et al. Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors , 1981, The Journal of experimental medicine.
[19] C. Uyttenhove,et al. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis , 1980, The Journal of experimental medicine.
[20] G. Klein,et al. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. , 1960, Cancer research.
[21] R. Prehn,et al. Immunity to methylcholanthrene-induced sarcomas. , 1957, Journal of the National Cancer Institute.